Clin2
NCT06948487Likely a fitRecruiting

Study of Fexuclu tablets for stomach inflammation (gastritis)

Gastritis

Part of Digestive system, Immune system & allergy, Lungs & breathing clinical trials.

This study watches patients with acute or chronic gastritis who are already being prescribed the stomach medicine Fexuclu (fexuprazan). It collects information to see how well the medicine works and if it causes any side effects in everyday use.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
12,000 people
Ages
19 years to 75 years
Study type
Observational

Who can take part

  • You are between 19 and 75 years old.
  • Your doctor plans to prescribe Fexuclu tablets (fexuprazan) for your stomach condition.
  • You have at least one stomach symptom, like pain, burning, or nausea, that needs treatment.
  • You understand the study and agree to let the researchers use your medical data.
  • You do not have any medical reason that would make fexuprazan unsafe for you.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07717775Not yet recruiting· Phase 1
Multiple-dose study of three test medicines in healthy adults

This study compares three different versions of a medicine to see how they act in the body and how safe they are. Healthy adults take the medicine by mouth several times so researchers can compare them.

Seoul
NCT07631065Not yet recruiting· Phase 4
Treatment for acute or chronic gastritis

This study tests an experimental treatment for people with acute or chronic gastritis, which is inflammation or irritation of the stomach lining. It aims to see if the treatment helps heal stomach erosions (small sores) seen during an endoscopy.

NCT07558707Not yet recruiting
Fexuclue for preventing NSAID-related stomach ulcers in everyday use

This study tests a medication called Fexuclue to see how well it prevents stomach ulcers in people who take NSAIDs (common pain relievers) for conditions like arthritis or chronic pain. If you need long-term NSAID therapy, this treatment might help protect your stomach.

Seoul
NCT07479056Recruiting
Fexuprazan to prevent stomach bleeding in heart patients on two blood thinners

This trial tests whether fexuprazan can prevent upper gastrointestinal bleeding in people at high risk who need two antiplatelet drugs for at least 6 months after a heart stent. If you are on dual antiplatelet therapy after a stent and have risk factors like older age, low weight, or history of ulcers, this study may help protect your stomach.

Seoul, Eunpyeong-gu
NCT07533266Not yet recruiting· Phase 4
Preventing stomach ulcers from NSAID pain relievers

This trial tests a new medicine, fexuprazan, to see if it can prevent stomach ulcers caused by taking NSAID pain relievers for a long time. If you need daily NSAIDs for arthritis or other muscle/bone pain, this medicine might help protect your stomach.

Seoul
NCT07277712Not yet recruiting· Phase 1
Study of a new tablet for healthy adults

This study tests a new tablet in healthy adults to see how the body processes it and whether food changes its effects. It helps determine the right dose and safety for future patients.

Jeonju

Hear when a new Gastritis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.